Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. Commentary

Saved in:
Bibliographic Details
Published inAIDS (London) Vol. 19; no. 1; pp. 15 - 23
Main Authors MCCOMSEY, Grace A, PAULSEN, Denise M, ROSS, Steve T, HERNANDEZ, Jaime E, ROSS, Lisa L, BRINKMAN, Kees, LONERGAN, J. Tyler, HESSENTHALER, Siegrid M, HOPPEL, Charles L, WILLIAMS, Vanessa C, FISHER, Robin L, CHERRY, Catherine L, WHITE-OWEN, Cathy, THOMPSON, Katherine A
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 2005
Subjects
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Biological and medical sciences
Dermatology
Infectious diseases
Medical sciences
Pharmacology. Drug treatments
Skin involvement in other diseases. Miscellaneous. General aspects
Skin disease
Purine nucleoside
Antiretroviral agent
RNA-directed DNA polymerase
Adipose tissue
Toxicity
Mitochondrial DNA
Stavudine
Reverse transcriptase inhibitor
Nucleoside analog
Antiviral
lipoatrophystavudine
Pyrimidine nucleoside
Immunopathology
electron transport chain
Hyperlactacidemia
Enzyme
Transferases
Enzyme inhibitor
AIDS
Immune deficiency
Infection
Nucleotidyltransferases
Metabolic disorder
Lipoatrophy
Dideoxynucleoside
Viral disease
Abacavir
Adipose tissue disorders
Lactic acid
mitochondrial toxicity
Zidovudine
Apoptosis
Online AccessGet full text

Cover

More Information
ISSN:0269-9370
1473-5571